Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [8217]

Warfarin associated with lower risk of cancer incidence in over 50s

Warfarin associated with lower risk of cancer incidence in over 50s

Biologics do not increase the risk of second malignancy in rheumatoid arthritis patients

Biologics do not increase the risk of second malignancy in rheumatoid arthritis patients

Onalespib could be an effective treatment for glioblastoma, preclinical studies show

Onalespib could be an effective treatment for glioblastoma, preclinical studies show

Combined therapies increase adverse side effects for patients with advanced hormone receptor-positive breast cancer

Combined therapies increase adverse side effects for patients with advanced hormone receptor-positive breast cancer

Bacteria in the gut modulates response to immunotherapy in melanoma

Bacteria in the gut modulates response to immunotherapy in melanoma

Last Month in Oncology with Dr. Bishal Gyawali: October 2017

Last Month in Oncology with Dr. Bishal Gyawali: October 2017

FDA grants accelerated approval to acalabrutinib for mantle cell lymphoma

FDA grants accelerated approval to acalabrutinib for mantle cell lymphoma

Researchers find genetic pathways to individualised treatment for advanced prostate cancer

Researchers find genetic pathways to individualised treatment for advanced prostate cancer

Deterioration of patients’ quality of life is delayed if progression of advanced or metastatic breast cancer is delayed

Deterioration of patients’ quality of life is delayed if progression of advanced or metastatic breast cancer is...

Gut microbiome may make chemo drug toxic to patients

Gut microbiome may make chemo drug toxic to patients

More from ecancer